Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

USA CPI (YoY) for Jun 9.100% vs 8.800% Est; Prior 8.600%

USA CPI (YoY) for Jun 9.100% vs 8.800% consensus estimate. The prior reading was 8.600%.

byBill Haddad

July 13, 2022

1 minute read

USA CPI (YoY) for Jun 9.100% vs 8.800% consensus estimate. The prior reading was 8.600%.

Why Microbot Medical Shares Are Sliding Today

By Adam Eckert

Today, 9:55 PM

Microbot Medical Inc (NASDAQ: MBOT) is trading lower Tuesday as the stock pulls back following Monday's strength.

MBOT

BMO Capital Maintains Outperform on Xebec Adsorption, Lowers Price Target to C$4.5

By Benzinga Newsdesk

Today, 9:55 PM

BMO Capital maintains Xebec Adsorption (TSX:XBC) with a Outperform and lowers the price target from C$5.6 to C$4.5.

TSX:XBC

HOOKIPA Gets FDA Nod For Initial-Stage Prostate Cancer Study

By Ragothaman Srinivasan

Today, 9:55 PM

The U.S. Food and Drug Administration (FDA) has accepted HOOKIPA Pharma’s (NASDAQ: HOOK) Investigational New Drug (IND) application for HB-300, a novel arenaviral immunotherapy for the treatment of metastatic castration-resistant prostate cancer.

HOOK

Barclays Announced CEO C.S. Venkatakrishnan Announced He Will be Undergoing Treatment for Non-Hodgkin Lymphoma

By Charles Gross

Today, 9:55 PM

-Reuters https://www.reuters.com/world/uk/barclays-says-ceo-undergo-cancer-treatment-work-home-2022-11-28/

BCS

USA CPI (YoY) for Jun 9.100% vs 8.800% Est; Prior 8.600%

Related Posts

Why Microbot Medical Shares Are Sliding Today

BMO Capital Maintains Outperform on Xebec Adsorption, Lowers Price Target to C$4.5

HOOKIPA Gets FDA Nod For Initial-Stage Prostate Cancer Study

Barclays Announced CEO C.S. Venkatakrishnan Announced He Will be Undergoing Treatment for Non-Hodgkin Lymphoma